Cargando…

Syndecan-4 as a Pathogenesis Factor and Therapeutic Target in Cancer

Cancer is an important cause of morbidity and mortality worldwide. Advances in research on the biology of cancer revealed alterations in several key pathways underlying tumorigenesis and provided molecular targets for developing new and improved existing therapies. Syndecan-4, a transmembrane hepara...

Descripción completa

Detalles Bibliográficos
Autores principales:	Onyeisi, Jessica Oyie Sousa, Lopes, Carla Cristina, Götte, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065655/ https://www.ncbi.nlm.nih.gov/pubmed/33810567 http://dx.doi.org/10.3390/biom11040503

Ejemplares similares

Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets
por: Oto, Julia, et al.
Publicado: (2023)

The Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 Promotes Ovarian Cancer Pathogenesis
por: Hillemeyer, Lara, et al.
Publicado: (2022)

Syndecan-1 as a Regulator of Chemokine Function
por: Götte, Martin, et al.
Publicado: (2003)

Acquisition of Anoikis Resistance Up-Regulates Syndecan-4 Expression in Endothelial Cells
por: Carneiro, Bruna Ribeiro, et al.
Publicado: (2014)

Syndecan-1-Dependent Regulation of Heparanase Affects Invasiveness, Stem Cell Properties, and Therapeutic Resistance of Caco2 Colon Cancer Cells
por: Katakam, Sampath Kumar, et al.
Publicado: (2020)

Syndecan-4 in Tumor Cell Motility
por: Keller-Pinter, Aniko, et al.
Publicado: (2021)

Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma
por: Motta, Juliana Maria, et al.
Publicado: (2023)

The Heparan Sulfate Proteoglycan Syndecan-1 Triggers Breast Cancer Cell-Induced Coagulability by Induced Expression of Tissue Factor
por: Hassan, Nourhan, et al.
Publicado: (2023)

Syndecan-3 and syndecan-4 are enriched in Schwann cell perinodal processes
por: Goutebroze, Laurence, et al.
Publicado: (2003)

An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ
por: Götte, Martin, et al.
Publicado: (2007)

Physiological and anatomical aspects of the reproduction of mice with reduced Syndecan-1 expression
por: Gougoula, Christina, et al.
Publicado: (2019)

Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies
por: Pires, Mariana, et al.
Publicado: (2023)

Role of syndecan-1 in the interaction between dendritic cells and T cells
por: Kouwenberg, M., et al.
Publicado: (2020)

Syndecan-1 knock-down in decidualized human endometrial stromal cells leads to significant changes in cytokine and angiogenic factor expression patterns
por: Baston-Büst, Dunja M, et al.
Publicado: (2010)

Syndecans as Modulators and Potential Pharmacological Targets in Cancer Progression
por: Barbouri, Despoina, et al.
Publicado: (2014)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Inhibition of Syndecan-4 by therapeutic antibodies reduces TNFα dependent joint destruction in mice
por: Stratis, Athanasios, et al.
Publicado: (2012)

Syndecan-1 Promotes Angiogenesis in Triple-Negative Breast Cancer through the Prognostically Relevant Tissue Factor Pathway and Additional Angiogenic Routes
por: Nassar, Eyyad, et al.
Publicado: (2021)

The heparan sulfate proteoglycan Syndecan-1 influences local bone cell communication via the RANKL/OPG axis
por: Timmen, Melanie, et al.
Publicado: (2020)

Differential Impact of Membrane-Bound and Soluble Forms of the Prognostic Marker Syndecan-1 on the Invasiveness, Migration, Apoptosis, and Proliferation of Cervical Cancer Cells
por: Hilgers, Katharina, et al.
Publicado: (2022)

The Role and Therapeutic Value of Syndecan-1 in Cancer Metastasis and Drug Resistance
por: Guo, Sen, et al.
Publicado: (2022)

Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma
por: Binder Gallimidi, Adi, et al.
Publicado: (2017)

The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4(+) T cell polarization in inflammatory and non-inflammatory breast cancer patients
por: Saleh, Moshira Ezzat, et al.
Publicado: (2019)

Syndecans in tumor cell adhesion and signaling
por: Beauvais, DeannaLee M, et al.
Publicado: (2004)

Syndecan-4 is a Novel Therapeutic Target for Intervertebral Disc Degeneration via Suppressing JNK/p53 Pathway
por: Ge, Jun, et al.
Publicado: (2020)

The expression of syndecan-1, syndecan-4 and decorin in healthy human breast tissue during the menstrual cycle
por: Hallberg, Gunilla, et al.
Publicado: (2010)

Syndecan-4 as a genetic determinant of the metabolic syndrome
por: Crocco, Paolina, et al.
Publicado: (2023)

Fibroblast growth factor–specific modulation of cellular response by syndecan-4
por: Horowitz, Arie, et al.
Publicado: (2002)

The Pathogenesis of Sepsis and Potential Therapeutic Targets
por: Huang, Min, et al.
Publicado: (2019)

Mycobacterium tuberculosis: Pathogenesis and therapeutic targets
por: Yang, Jiaxing, et al.
Publicado: (2023)

The pathogenesis and potential therapeutic targets in sepsis
por: Zhang, Wendan, et al.
Publicado: (2023)

Significance of the Syndecan-4-Transglutaminase-2 Interaction
por: Verderio, Elisabetta, et al.
Publicado: (2010)

Erratum: The role and therapeutic value of syndecan-1 in cancer metastasis and drug resistance
por: Frontiers Production Office,
Publicado: (2022)

Role of GLI Transcription Factors in Pathogenesis and Their Potential as New Therapeutic Targets
por: Sabol, Maja, et al.
Publicado: (2018)

Pathogenesis and Potential Therapeutic Targets for Triple-Negative Breast Cancer
por: Li, Chia-Jung, et al.
Publicado: (2021)

Syndecan-1 (CD138), Carcinomas and EMT
por: Couchman, John R.
Publicado: (2021)

Syndecan-4 Phosphorylation Is a Control Point for Integrin Recycling
por: Morgan, Mark R., et al.
Publicado: (2013)

Syndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and Prognostication
por: Szatmári, Tünde, et al.
Publicado: (2015)

Correction: Syndecan-4 as a genetic determinant of the metabolic syndrome
por: Crocco, Paolina, et al.
Publicado: (2023)

Pathogenesis of Preeclampsia and Therapeutic Approaches Targeting the Placenta
por: Jena, Manoj Kumar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_09daafugphhkl9ktp868nq38bu